Alpha-lipoic acid activates AMPK to protect against oxidative stress and apoptosis in rats with diabetic peripheral neuropathy
Authors:
- 27 October 2022
- journal article
- research article
- Published by Springer Nature in Hormones
- Vol. 22 (1) , 95-105
Abstract
Purpose To investigate the AMPK pathway–mediated effect of alpha-lipoic acid (ALA) on the dorsal root ganglia (DRGs) of rats with diabetic peripheral neuropathy (DPN) and to attempt to elucidate the underlying mechanism. Methods Sprague-Dawley rats (n = 15) were randomly divided into three groups. The control group was fed a standard diet, and the other groups were fed a high-carbohydrate/high-fat diet. Diabetes was established by a single streptozotocin (STZ) (30 mg/kg) injection, and control rats were injected with an equal volume of citrate buffer. ALA (60 mg/kg/day) was administered for 12 weeks. The nerve conduction velocity (NCV) of the sciatic nerve was measured. Glutathione (GSH) and malondialdehyde (MDA) concentrations in serum were measured with the thiobarbituric acid method and biochemistry. Pathological changes in the rat DRGs were observed. AMPK, phospho-AMPK (p-AMPK), nuclear factor erythroid-2-related factor 2 (Nrf2), phospho-nuclear factor erythroid-2-related factor 2 (p-Nrf2), heme oxygenase 1 (HO-1), quinone oxidoreductase 1 (NQO1), Forkhead box O3 (FoxO3a), phospho-Forkhead box O3 (p-FoxO3a), and Bcl-2 interacting mediator of cell death (Bim) expression levels were assessed by immunohistochemistry and western blotting. Results ALA improved the motor NCV (MNCV) and sensory NCV (SNCV) of rats with DPN and reduced their mechanical pain threshold. ALA increased serum GSH concentrations and decreased serum MDA concentrations. Additionally, AMPK was activated by ALA. Nrf2, p-Nrf2, HO-1, and NQO1 expression was upregulated, while FoxO3a, p-FoxO3a, and Bim expression was downregulated. ALA reduced oxidative stress and apoptosis in DRG. Conclusion ALA alleviates DPN and improves peripheral nerve function. ALA reduces oxidative stress by activating Nrf2 through AMPK and inhibits FoxO3a and Bim thereby reducing neuronal apoptosis.Keywords
This publication has 45 references indexed in Scilit:
- Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical TrialsCurrent Diabetes Reports, 2014
- Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of theEASD(Neurodiab)Journal of the Peripheral Nervous System, 2014
- The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathyNeuroscience, 2014
- Alpha-Lipoic Acid Attenuates Renal Injury in Rats with Obstructive NephropathyBioMed Research International, 2013
- Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respirationBiology Open, 2013
- The Akt–FoxO3a–manganese superoxide dismutase pathway is involved in the regulation of oxidative stress in diabetic nephropathyExperimental Physiology, 2013
- The mitochondrial H+-ATP synthase and the lipogenic switchCell Cycle, 2013
- Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and managementDiabetes/Metabolism Research and Reviews, 2011
- Mammalian Sirtuins: Biological Insights and Disease RelevanceAnnual Review of Pathology: Mechanisms of Disease, 2010
- Mechanisms of disease: The oxidative stress theory of diabetic neuropathyReviews in Endocrine and Metabolic Disorders, 2008